Eli Lilly’s Cyramza rallies back in liver cancer with biomarker win
After Eli Lilly’s Cyramza flopped...
Read MoreAfter Eli Lilly’s Cyramza flopped...
Read MoreBoehringer Ingelheim and OSE Immunotherapeutics,...
Read MoreBiotechnology company Allogene Therapeutics has...
Read MoreAn organic chemical compound shows...
Read MoreEach year, dozens of branded...
Read MoreAstraZeneca today announced the US...
Read MoreMicrosatellite instability-high (MSI) testing alone...
Read MoreThe Food and Drug Administration...
Read MoreTeens are snorting condoms for...
Read MoreProspectus approved by the FSMA...
Read More